Barclays PLC Incyte Corp Put Options Transaction History

Barclays PLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $1.7 Million - $2 Million	30,000 New	30,000 $1.71 Million
Q2 2020 Aug 12, 2020	SELL	$74.18 - $108.93 $3.24 Million - $4.76 Million	-43,700 Reduced 82.45%	9,300 $967,000
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $8.45 Million - $11.5 Million	-133,800 Reduced 71.63%	53,000 $3.88 Million
Q4 2019 Feb 10, 2020	SELL	$73.04 - $95.72 $1.37 Million - $1.79 Million	-18,700 Reduced 9.1%	186,800 $16.3 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $1.84 Million - $2.19 Million	25,300 Added 14.04%	205,500 $15.3 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $154,392 - $186,270	2,100 Added 1.18%	180,200 $15.3 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $15.7 Million - $21.7 Million	-246,600 Reduced 58.06%	178,100 $15.3 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $12.4 Million - $14.8 Million	211,600 Added 99.3%	424,700 $27 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $543,400 - $653,224	-8,800 Reduced 3.97%	213,100 $14.7 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $16.3 Million - $22.5 Million	-267,600 Reduced 54.67%	221,900 $14.9 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $8.84 Million - $10.7 Million	-106,400 Reduced 17.86%	489,500 $40.8 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $26.1 Million - $32.5 Million	278,800 Added 87.92%	595,900 $56.4 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $34.6 Million - $43.8 Million	317,100	317,100 $37 Million

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.